{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T21:11:22Z","timestamp":1785013882334,"version":"3.55.0"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T00:00:00Z","timestamp":1513814400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Competence Network Heart Failure Germany"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0188491","type":"journal-article","created":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T14:20:13Z","timestamp":1513866013000},"page":"e0188491","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Clinical predictors of outcome in patients with inflammatory dilated cardiomyopathy"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7996-7019","authenticated-orcid":true,"given":"Konstantinos","family":"Karatolios","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Holzendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Hatzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Tousoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Schieffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Pankuweit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,12,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Caforio ALP, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. The Oxford University Press; 2013. pp. 2636\u201348\u20132648a\u20132648d.","DOI":"10.1093\/eurheartj\/eht210"},{"issue":"15","key":"ref2","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMra0800028","article-title":"Myocarditis","volume":"360","author":"LT Cooper","year":"2009","journal-title":"N Engl J Med. Massachusetts Medical Society"},{"issue":"15","key":"ref3","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1056\/NEJM200004133421502","article-title":"Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy","volume":"342","author":"GM Felker","year":"2000","journal-title":"N Engl J Med"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1056\/NEJM199508033330501","article-title":"A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators","volume":"333","author":"JW Mason","year":"1995","journal-title":"N Engl J Med. Massachusetts Medical Society"},{"issue":"9","key":"ref5","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jacc.2011.09.074","article-title":"Update on myocarditis","volume":"59","author":"I Kindermann","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0008-6363(01)00261-9","article-title":"Postmortem diagnosis in sudden cardiac death victims: macroscopic, microscopic and molecular findings","volume":"50","author":"C Basso","year":"2001","journal-title":"Cardiovasc Res"},{"issue":"10","key":"ref7","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.healun.2010.08.007","article-title":"The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report\u20142010","volume":"29","author":"J Stehlik","year":"2010","journal-title":"J Heart Lung Transplant. Elsevier"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1161\/CIRCULATIONAHA.108.769489","article-title":"Predictors of Outcome in Patients With Suspected Myocarditis","volume":"118","author":"I Kindermann","year":"2008","journal-title":"Circulation"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.carpath.2014.01.004","article-title":"Detailed pathologic evaluation on endomyocardial biopsy provides long-term prognostic information in patients with acute myocarditis","volume":"23","author":"JC Young","year":"2014","journal-title":"Cardiovascular Pathology. Elsevier Inc"},{"issue":"12","key":"ref10","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/ejhf.579","article-title":"Endomyocardial miR-133a levels correlate with myocardial inflammation, improved left ventricular function, and clinical outcome in patients with inflammatory cardiomyopathy","volume":"18","author":"C Besler","year":"2016","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"ref11","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1093\/eurheartj\/ehm076","article-title":"A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis","volume":"28","author":"ALP Caforio","year":"2007","journal-title":"Eur Heart J"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.ijcard.2016.06.167","article-title":"Long-term outcome and predictors of outcome in patients with non-ischemic dilated cardiomyopathy","volume":"220","author":"K Karatolios","year":"2016","journal-title":"Int J Cardiol"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","article-title":"Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"29","author":"P Elliott","year":"2008","journal-title":"Eur Heart J"},{"issue":"23","key":"ref14","first-page":"1850","article-title":"Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases","volume":"37","author":"YM Pinto","year":"2016","journal-title":"Eur Heart J. The Oxford University Press"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0046-8177(03)00078-9","article-title":"Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens","volume":"34","author":"S Pankuweit","year":"2003","journal-title":"Hum Pathol"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"AS Levey","year":"1999","journal-title":"Ann Intern Med"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0735-1097(03)00789-7","article-title":"The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure","volume":"42","author":"JP Curtis","year":"2003","journal-title":"JACC"},{"issue":"15","key":"ref18","first-page":"2180","article-title":"Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program","volume":"110","author":"SD Solomon","year":"2004","journal-title":"Circulation. Lippincott Williams & Wilkins"},{"issue":"1","key":"ref19","first-page":"65","article-title":"Predictors of mortality and morbidity in patients with chronic heart failure","volume":"27","author":"SJ Pocock","year":"2006","journal-title":"Eur Heart J. The Oxford University Press"},{"issue":"6","key":"ref20","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1067\/mhj.2002.126446","article-title":"The relevance of subgroup-specific treatment effects: the Studies Of Left Ventricular Dysfunction (SOLVD) revisited","volume":"144","author":"AB Parker","year":"2002","journal-title":"Am Heart J. Elsevier"},{"issue":"1","key":"ref21","first-page":"1","article-title":"Inflammatory mediators and reversible myocardial dysfunction","volume":"195","author":"H Kan","year":"2003","journal-title":"J Cell Physiol. Wiley Subscription Services, Inc., A Wiley Company"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s00380-014-0618-0","article-title":"Correlations of the changes in bioptic findings with echocardiographic, clinical and laboratory parameters in patients with inflammatory cardiomyopathy","volume":"31","author":"J Krejci","year":"2016","journal-title":"Heart Vessels"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0735-1097(01)01470-X","article-title":"Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction","volume":"38","author":"A Al-Ahmad","year":"2001","journal-title":"JACC"},{"issue":"5","key":"ref24","first-page":"671","article-title":"Renal function as a predictor of outcome in a broad spectrum of patients with heart failure","volume":"113","author":"HL Hillege","year":"2006","journal-title":"Circulation. Lippincott Williams & Wilkins"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1536\/ihj.52.366","article-title":"Impact of mild to moderate renal dysfunction on left ventricular relaxation function and prognosis in ambulatory patients with nonischemic dilated cardiomyopathy","volume":"52","author":"K Ohshima","year":"2011","journal-title":"Int Heart J"},{"issue":"9","key":"ref26","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2459\/JCM.0b013e328356a2fd","article-title":"Renal function has an effect on cardiovascular mortality in patients with dilated cardiomyopathy","volume":"13","author":"G Erta\u015f","year":"2012","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"13","key":"ref27","first-page":"1764","article-title":"Prolonged QTc interval and high B-type natriuretic peptide levels together predict mortality in patients with advanced heart failure","volume":"107","author":"B Vrtovec","year":"2003","journal-title":"Circulation. Lippincott Williams & Wilkins"},{"issue":"18","key":"ref28","first-page":"1335","article-title":"The relationship between QT intervals and mortality in ambulant patients with chronic heart failure. The united kingdom heart failure evaluation and assessment of risk trial (UK-HEART)","volume":"20","author":"P Brooksby","year":"1999","journal-title":"Eur Heart J. The Oxford University Press"},{"issue":"16","key":"ref29","first-page":"2011","article-title":"Electrocardiographic and cardiac magnetic resonance imaging parameters as predictors of a worse outcome in patients with idiopathic dilated cardiomyopathy","volume":"30","author":"V Hombach","year":"2009","journal-title":"Eur Heart J. The Oxford University Press"},{"issue":"4","key":"ref30","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/eurjhf\/hfq229","article-title":"Prognostic electrocardiographic parameters in patients with suspected myocarditis","volume":"13","author":"C Ukena","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"ref31","first-page":"1787","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC","volume":"Vol. 33","author":"JJV McMurray","year":"2012","journal-title":"European heart journal. The Oxford University Press"},{"issue":"10","key":"ref32","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.jacc.2006.01.060","article-title":"Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program","volume":"47","author":"LG Olsson","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"ref33","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/eurjhf\/hfr066","article-title":"Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction","volume":"13","author":"GCM Linssen","year":"2011","journal-title":"Eur J Heart Fail"},{"issue":"23","key":"ref34","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1093\/eurheartj\/ehl359","article-title":"Atrial fibrillation, ischaemic heart disease, and the risk of death in patients with heart failure","volume":"27","author":"OD Pedersen","year":"2006","journal-title":"Eur Heart J"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"i4482","DOI":"10.1136\/bmj.i4482","article-title":"Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis","volume":"354","author":"A Odutayo","year":"2016","journal-title":"BMJ"},{"issue":"8","key":"ref36","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM199702203360801","article-title":"The Effect of Digoxin on Mortality and Morbidity in Patients with Heart Failure","volume":"336","year":"1997","journal-title":"N Engl J Med"},{"issue":"12","key":"ref37","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1253\/jcj.63.934","article-title":"High doses of digitalis increase the myocardial production of proinflammatory cytokines and worsen myocardial injury in viral myocarditis: a possible mechanism of digitalis toxicity","volume":"63","author":"A Matsumori","year":"1999","journal-title":"Jpn Circ J"},{"issue":"13","key":"ref38","first-page":"1965","article-title":"Viral persistence in the myocardium is associated with progressive cardiac dysfunction","volume":"112","author":"U K\u00fchl","year":"2005","journal-title":"Circulation. American Heart Association, Inc"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0188491","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T08:04:27Z","timestamp":1570521867000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0188491"}},"subtitle":[],"editor":[{"given":"Wolfgang Rudolf","family":"Bauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,12,21]]},"references-count":38,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,12,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0188491","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,21]]}}}